Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities

Abstract

In the largest genomic evaluation of MPT to date, multiple clinically actionable mutations were found. Routine sequencing of metastatic MPT may provide additional information to guide treatment decisions and clinical trial enrollment.